Rockwell Medical, Inc. to Report Third Quarter 2021 Financial and Operating Results on November 15, 2021
November 08 2021 - 7:00AM
Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company
dedicated to transforming the treatment of iron deficiency and
anemia management and improving outcomes for patients around the
world, today announced that it will host a conference call on
Monday, November 15 at 4:00 PM ET to discuss its financial results
for the three months ended September 30, 2021, and recent
operational highlights.
To access the conference call, please dial (877)
383-7438 (local) or (678) 894-3975 (international) at least 10
minutes prior to the start time and refer to conference ID 7697945.
A live webcast of the call will be available under "Events &
Presentations" in the Investor section of the Company's website,
https://ir.rockwellmed.com/. An archived webcast will be available
on the Company's website approximately two hours after the event
and will be available for 30 days.
To submit questions in advance, please email
your questions to invest@rockwellmed.com.
About Rockwell Medical
Rockwell Medical is a commercial-stage
biopharmaceutical company developing and commercializing its
next-generation parenteral iron technology platform, Ferric
Pyrophosphate Citrate (FPC), which has the potential to lead
transformative treatments for iron deficiency in multiple disease
states, reduce healthcare costs and improve patients’ lives. The
Company has two FDA-approved therapies indicated for patients
undergoing hemodialysis, which are the first two products developed
from the FPC platform. The Company is developing FPC for the
treatment of iron deficiency in patients outside of dialysis, who
are receiving intravenous medications in the home infusion setting,
a large and rapidly growing segment of healthcare, and where these
patients suffer from chronic diseases associated with high
incidence of iron deficiency and anemia. In addition, Rockwell
Medical is one of two major suppliers of life-saving hemodialysis
concentrate products to kidney dialysis clinics in the United
States. For more information, visit www.RockwellMed.com.
CONTACTS
Investors:Argot
Partners212.600.1902Rockwell@argotpartners.com
Media:David RosenArgot
Partners212.600.1902david.rosen@argotpartners.com
Rockwell Medical (NASDAQ:RMTI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Rockwell Medical (NASDAQ:RMTI)
Historical Stock Chart
From Sep 2023 to Sep 2024